Short-Term Resveratrol Exposure Causes In Vitro and In Vivo Growth Inhibition and Apoptosis of Bladder Cancer Cells

Inhibition of STAT3 Expression and Signaling in Resveratrol-Differentiated Medulloblastoma Cells

(2015) Li-Jun Yu et al.   NEOPLASIA

Recent advances in the diagnosis and treatment of bladder cancer

(2013) Grace Cheung et al.   BMC Medicine

Resveratrol Induces Cell Cycle Arrest and Apoptosis in Malignant NK Cells via JAK2/STAT3 Pathway Inhibition

(2013) Ly Quoc Trung et al.   PLoS One

Resveratrol Inhibits CD4+ T Cell Activation by Enhancing the Expression and Activity of Sirt1

(2013) Ting Zou et al.   PLoS One

Regulation of FOXOs and p53 by SIRT1 Modulators under Oxidative Stress

(2013) Yusuke S. Hori et al.   PLoS One

Experience with Newer Intravesical Chemotherapy for High-Risk Non-Muscle-Invasive Bladder Cancer

(2013) LaMont J. Barlow et al.   Current Urology Reports

The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway

(2012) Hui-Jye Chen et al.   BIOCHEMICAL PHARMACOLOGY

Everolimus combined with cisplatin has a potential role in treatment of urothelial bladder cancer

(2012) Rosário Pinto-Leite et al.   BIOMEDICINE & PHARMACOTHERAPY

Intravesical chemotherapy plus bacille Calmette-Guérin in non-muscle invasive bladder cancer: a systematic review with meta-analysis

(2012) Baerin B. Houghton et al.   BJU INTERNATIONAL

Resveratrol induces downregulation of DNA repair genes in MCF-7 human breast cancer cells

(2012) Ismael Leon-Galicia et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Neoadjuvant Short-term Intensive Intravesical Mitomycin C Regimen Compared with Weekly Schedule for Low-grade Recurrent Non–muscle-invasive Bladder Cancer: Preliminary Results of a Randomised Phase 2 Study

(2012) Renzo Colombo et al.   EUROPEAN UROLOGY

Impaired SIRT1 nucleocytoplasmic shuttling in the senescent heart during ischemic stress

(2012) Chao Tong et al.   FASEB JOURNAL

Resveratrol induces apoptosis associated with mitochondrial dysfunction in bladder carcinoma cells

(2012) Xi Lin et al.   INTERNATIONAL JOURNAL OF UROLOGY

Dose-dependent effect of Resveratrol on bladder cancer cells: Chemoprevention and oxidative stress

(2012) Bianca Stocco et al.   MATURITAS

Primary Effusion Lymphoma Cell Death Induced by Bortezomib and AG 490 Activates Dendritic Cells through CD91

(2012) Mara Cirone et al.   PLoS One

Reduced Expression of von Hippel-Lindau Protein Correlates with Decreased Apoptosis and High Chondrosarcoma Grade

(2011) Changbao Chen et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

Metabolic Patterns and Biotransformation Activities of Resveratrol in Human Glioblastoma Cells: Relevance with Therapeutic Efficacies

(2011) Xiao-Hong Shu et al.   PLoS One

Identification of metabolic pattern and bioactive form of resveratrol in human medulloblastoma cells

(2010) Xiao-Hong Shu et al.   BIOCHEMICAL PHARMACOLOGY

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Inhibition of NF-κB signaling commits resveratrol-treated medulloblastoma cells to apoptosis without neuronal differentiation

(2010) Shu Wen et al.   JOURNAL OF NEURO-ONCOLOGY

Mouse orthotopic models for bladder cancer research

(2009) Eddie Chan et al.   BJU INTERNATIONAL

Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cellsin vitroand inhibits tumor growthin vivo

(2009) Yu Bai et al.   CANCER SCIENCE

The p53 Pathway Encounters the MicroRNA World

(2009) Apana Takwi et al.   CURRENT GENOMICS

Intravesical Chemotherapy of High-Grade Bladder Cancer with HTI-286, A Synthetic Analogue of the Marine Sponge Product Hemiasterlin

(2008) B. A. Hadaschik et al.   CLINICAL CANCER RESEARCH

Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survival

(2008) Chun-Liang Chen et al.   Molecular Cancer